020-000-355 Oligomeric Hyaluronic Acid (Oligo-HA), Degraded by Hyaluronidase

About This Item

Catalog No.
020-000-355
Product Name Oligomeric Hyaluronic Acid (Oligo-HA) Degraded by Hyaluronidase
CAS No. 9067-32-7
Appearance White or almost white powder
Type Sodium Salt
Keywords Sodium Hyaluronate, Hyaluronic Acid
Related products Hyacross™ Hyaluronic Acid Elastomer, Hymagic™ -AcHA Sodium Acetylated Hyaluronate, Hymagic™-4D, cationHA™ Substantive Sodium Hyaluronate

Quantity

kg

Technical Service

Need help? Our team of experienced scientists is here for you.

Description

Oligomeric Hyaluronic Acid (Oligo-HA) Description


Oligomeric Hyaluronic Acid (Oligo-HA) is a new product developed by bio-enzymatic degradation technology. Its molecular weight varies from 3,000Da to 10,000Da, allowing it to be absorbed more easily by the skin and thus have a deep moisturizing effect.

Oligomeric Hyaluronic Acid (Oligo-HA) Specification


Oligomeric Hyaluronic Acid (Oligo-HA) has a molecular weight 3,000Da~10,000Da and the average molecule size is less than 25nm, so it penetrates easily into the skin and nourishes the skin.

Product Name Oligomeric Hyaluronic Acid (Oligo-HA), Degraded by Hyaluronidase
Molecular Weight 3,000Da~10,000Da
Assay of HA ≥ 95%
Glucuronic Acid ≥46%
pH 5.0-8.0
Transparency ≥99.0%
Protein ≤0.05%
Heavy Metals ≤20ppm
Loss on Drying ≤10.0%
Arsenic ≤ 2ppm
Bacterial count <100cfu/g
Mold and yeast <20cfu/g
Residue on Ignition ≤20.0%
Intrinsic viscosity ≤0.47dL/g
Escherichia Coli Negative
Staphylococcus aureus Negative
Pseudomonas aeruginosa Negative
Storage Lightproof, ordinary temperature, and sealed container
Validity Two Years

 

Oligomeric Hyaluronic Acid (Oligo-HA) Applications


In the Cosmetic Field

  • Transdermal absorption, deep moisturizing
  • Repairing damaged cells and scavenging free radicals
  • Anti-aging


In the Food Health Field

  • Strong water retention and water retention capacity


In the Medical Field

  • Antioxidant
  • Anti-tumor
  • Immunomodulatory
  • Inflammatory and wound healing
  • Pro-angiogenic


Oligomeric Hyaluronic Acid (Oligo-HA) is developed by bio-enzymatic degradation technology. In mammals, the enzymatic degradation of HA results from the action of three types of enzymes: hyaluronidase (hyase), b-d-glucuronidase, and β-Nacetyl-hexosaminidase. Throughout the body, these enzymes are found in various forms, intracellularly and in serum.

In general, hyase cleaves high molecular weight HA into smaller oligosaccharides while β-d-glucuronidase and β-N-acetylhexosaminidase further degrade the oligosaccharide fragments by removing nonreducing terminal sugars (Leach and Schmidt, 2004).

The degradation products of hyaluronan, oligosaccharides, and very low molecular weight hyaluronan, exhibit pro-angiogenic properties (Mio and Stern, 2002).

By catalyzing the hydrolysis of hyaluronic acid, a major constituent of the interstitial barrier, hyaluronidase lowers the viscosity of hyaluronic acid, thereby increasing tissue permeability. It is, therefore, used in medicine in conjunction with other drugs in order to speed their dispersion and delivery.

Reference

 

  1. Necas , L. Bartosikova , P. Brauner , J. Kolar: Hyaluronic acid (hyaluronan): a review. Veterinarni Medicina, 53, 2008 (8): 397–411

Reviews

5 Stars
2
4 Stars
0
3 Stars
0
2 Stars
0
1 Stars
0
Write a review

Get a Quote

Send us an inquiry now to find out more information and the latest prices, thanks!
Product Name
Quantity
Name
Email
Phone
Company
Application
Country
United States
  • United States
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antarctica
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos (Keeling) Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Croatia
  • Cuba
  • Cyprus
  • Czech Republic
  • Democratic Republic of Congo
  • Denmark
  • Disputed Territory
  • Djibouti
  • Dominica
  • Dominican Republic
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Federated States of Micronesia
  • Fiji
  • Finland
  • France
  • French Guyana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Iraq-Saudi Arabia Neutral Zone
  • Ireland
  • Israel
  • Italy
  • Ivory Coast
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Libya
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands Antilles
  • Netherlands
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • North Korea
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestinian Territories
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Helena and Dependencies
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • Samoa
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and South Sandwich Islands
  • South Korea
  • Spain
  • Spratly Islands
  • Sri Lanka
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syria
  • Taiwan
  • Tajikistan
  • Tanzania
  • Thailand
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks And Caicos Islands
  • Tuvalu
  • US Virgin Islands
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • Uzbekistan
  • Vanuatu
  • Vatican City
  • Venezuela
  • Vietnam
  • Wallis and Futuna
  • Western Sahara
  • Yemen
  • Zambia
  • Zimbabwe
Comments
I would like to join the mailing list to receive updates from Stanford Chemicals.
Check Code